BBIO Form 144: Proposed resale of 83,088 shares

BBIO reported proposed sales of Common Stock via Form 144.

Rhea-AI Filing Summary

BBIO reported proposed sales of Common Stock via Form 144. The filing lists a stock option exercise tied to 83,088 shares dated 06/15/2026 with cash as the consideration method, and two restricted stock lots of 3,576 shares each dated 11/16/2020 and 11/16/2021. The entries are presented as securities to be sold by the reporting holder through the issuer pathway.

Insights

Securities Compliance Analyst

Form 144 lists proposed resale activity tied to option exercise and restricted stock lots.

The filing shows a stock option exercise associated with 83,088 shares on 06/15/2026, and two restricted stock entries of 3,576 shares each (dated 11/16/2020 and 11/16/2021.

These lines reflect the holder's intent to sell under Form 144 reporting rules; actual sales, timing, and cash‑flow recipients are not detailed in the excerpt. Subsequent transfer or sale filings would confirm execution and settlement.

Key Figures

Stock option exercise shares: 83,088 shares Restricted stock lot 1: 3,576 shares Restricted stock lot 2: 3,576 shares +1 more

4 metrics

Stock option exercise shares 83,088 shares stock option exercise dated 06/15/2026

Restricted stock lot 1 3,576 shares restricted stock dated 11/16/2020

Restricted stock lot 2 3,576 shares restricted stock dated 11/16/2021

Broker/Intermediary listed Morgan Stanley Smith Barney LLC 1 New York Plaza, 8th Floor, New York NY 10004

Key Terms

Form 144, Stock Option Exercise, Restricted Stock, Issuer pathway

4 terms

Form 144 regulatory

"Securities To Be Sold — lists securities "to be sold" and related dates"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 06/15/2026 | Stock Option Exercise | ISSUER"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock financial

"Common | 11/16/2020 | Restricted Stock | ISSUER"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Issuer pathway regulatory

"Entries labeled with "ISSUER" in the securities table"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BBIO's Form 144 report?

It reports proposed resale of common stock tied to a stock option exercise and restricted stock lots. The excerpt shows 83,088 shares linked to a stock option exercise on 06/15/2026 and two restricted stock lots of 3,576 shares each dated 11/16/2020 and 11/16/2021.

Does Form 144 mean the shares were sold?

Not necessarily; Form 144 indicates an intent to sell, not completion of a sale. The excerpt lists securities "to be sold" and dates but does not include confirmation of sale execution, settlement, or proceeds.

Who is the reported broker or intermediary for the transaction?

The broker listed is Morgan Stanley Smith Barney LLC at 1 New York Plaza. The excerpt includes that firm and an address, implying it may handle the resale transactions per the filing lines.

What consideration method is shown for the 83,088 shares?

The filing ties the 83,088-share stock option exercise to cash as the consideration method on 06/15/2026. No sale price or proceeds recipient details are provided in the excerpt.

Are the restricted stock lots free to be sold immediately?

The excerpt lists two restricted stock grants dated 11/16/2020 and 11/16/2021, each 3,576 shares. The filing does not state vesting or transfer restrictions; restriction status and transferability are not specified in the provided lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 05:34 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001754371
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BRIDGEBIO PHARMA, INC.
SEC File Number	001-38959
Address of Issuer	3160 Porter Drive Suite 250 Palo Alto CALIFORNIA 94304
Phone	(650) 391-9740
Name of Person for Whose Account the Securities are To Be Sold	JENNIFER COOK
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	90240	6012159.04	195861242	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2026	Stock Option Exercise	ISSUER			83088	06/15/2026	Cash
Common	11/16/2020	Restricted Stock	ISSUER			3576	11/16/2020	Not Applicable
Common	11/16/2021	Restricted Stock	ISSUER			3576	11/16/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Cook
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)